Home › Thyroid Cancer › Missouri › St. Louis
Thyroid Cancer clinical trials in St. Louis, MO
3 studies for Thyroid Cancer are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
RecruitingPhase 1/2
- Washington University, St Louis
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RecruitingPhase 1/2
- Washington University Infusion Center Pharmacy, St Louis
Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differentiated Thyroid Cancer (DTC)
RecruitingPhase 2
- Washington University School of Medicine, St Louis
About Thyroid Cancer
Your thyroid is a butterfly-shaped gland in your neck. There are several thyroid cancer types with different treatments. Discover options available.
More about Thyroid Cancer on MedlinePlus
Thyroid Cancer trials in other cities
- Houston, TX10 studies
- New York City, NY8 studies
- Washington, DC8 studies
- Boston, MA7 studies
- Los Angeles, CA5 studies
- San Francisco, CA4 studies
- Philadelphia, PA4 studies
- Durham, NC4 studies
- Nashville, TN4 studies
- Memphis, TN3 studies
- Baldwin Park, CA3 studies
- San Antonio, TX3 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer68 studies
- Breast Cancer63 studies
- Metastatic Cancer52 studies
- Cancer (all types)51 studies
- Colorectal Cancer51 studies
- Prostate Cancer45 studies
- Ovarian Cancer37 studies
- Lung Cancer37 studies
- Pancreatic Cancer33 studies
- Head and Neck Squamous Cell Carcinoma32 studies
- Endometrial Cancer29 studies
- Multiple Myeloma26 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.